Forest Laboratories, LLC v. Amneal Pharmaceuticals LLC

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Esther Salas · 2,573 cases in index

Docket number

2:17-cv-11680

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

11/15/2017

Date terminated

02/09/2018

623 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Forest Laboratories, LLC · 39 cases
• defendant · Amneal Pharmaceuticals, LLC Pharmaceuticals & Biotechnology · 178 cases

Part of a Larger Litigation Pattern

This is one of 179 Patent - ANDA cases in our index naming AMNEAL PHARMACEUTICALS, LLC — a possible mass-tort or coordinated-litigation cluster.

• Amneal Pharmaceuticals LLC v. Sandoz Inc
  District Court, D. New JerseyFiled 11/12/2025
• Amneal Pharmaceuticals LLC v. Sandoz Inc
  District Court, D. New JerseyFiled 01/07/2025
• Salix Pharmaceuticals, Inc v. Amneal Pharmaceuticals of New York, LLC
  District Court, D. New JerseyFiled 04/05/2024
• Celgene Corporation v. Amneal Pharmaceuticals of New York, LLC
  District Court, D. New JerseyFiled 01/26/2024
• Teva Branded Pharmaceutical Products R&D LLC v. Amneal Pharmaceuticals of New York, LLC
  District Court, D. New JerseyFiled 10/06/2023
• Allergan, Inc v. Amneal Pharmaceuticals of New York, LLC
  District Court, E.D. New YorkFiled 08/17/2023

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Forest Laboratories, LLC v. Amneal Pharmaceuticals LLC?

Forest Laboratories, LLC v. Amneal Pharmaceuticals LLC is a federal patent - anda lawsuit filed on 11/15/2017 in the District Court, D. New Jersey. The case was terminated on 02/09/2018. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 2:17-cv-11680.

When was the case filed?

Forest Laboratories, LLC v. Amneal Pharmaceuticals LLC was filed on 11/15/2017. It was terminated on 02/09/2018.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.